Jennifer Brancato Sahni
About Jennifer Brancato Sahni
Jennifer Brancato Sahni is a scientist at Bristol Myers Squibb in Redwood City, California, with a background in cancer research and extensive experience in academia and industry.
Company
Jennifer Brancato Sahni currently works as a scientist at Bristol Myers Squibb, located in Redwood City, California, United States. At Bristol Myers Squibb, she has contributed to a collaborative project focused on drug resistance mechanisms in cancer therapy and has mentored junior scientists and postdoctoral fellows in experimental design and data analysis.
Title
Jennifer Brancato Sahni holds the title of Scientist. She previously held positions such as Postdoctoral Fellow at the New York University School of Medicine, PhD Student at Case Western Reserve University, and Research Specialist at the University of Pennsylvania. Additionally, she has gained experience through various research and internship roles at institutions such as Boston Biomedical Research Institute, University of Geneva, Pottstown Memorial Hospital, and Lehigh Valley Health Network.
Education and Expertise
Jennifer Brancato Sahni earned her Doctor of Philosophy (PhD) from Case Western Reserve University School of Medicine, between 2012 and 2018. Prior to that, she completed her Bachelor of Arts (B.A.) at the College of the Holy Cross from 2005 to 2009. Her expertise includes cancer research, with a focus on the role of specific proteins in cancer progression and targeted cancer therapies. She has also presented novel findings at the 2022 American Association for Cancer Research (AACR) Annual Meeting.
Background
Jennifer Brancato Sahni has extensive experience in cancer research. She began her career as a research assistant at the University of Geneva through a self-created internship in 2007. She later worked as a research scholar in the Department of Gynecologic Oncology at Lehigh Valley Health Network and served as a student observer at Pottstown Memorial Hospital. Her professional journey includes significant roles such as a research specialist at the University of Pennsylvania and a postdoctoral fellow at the New York University School of Medicine.
Achievements
Jennifer Brancato Sahni has several notable achievements. She received a grant from the National Institutes of Health (NIH) for her research on targeted cancer therapies during her time at Case Western Reserve University. She has also published research on the role of specific proteins in cancer progression and presented findings on novel in vivo pharmacology models at the 2022 American Association for Cancer Research (AACR) Annual Meeting.